Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2019 1
2020 4
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Ciprofloxacin for treatment of drug-resistant epilepsy.
Cheraghmakani H, Rezai MS, Valadan R, Rahimzadeh G, Moradi M, Jahanfekr V, Moosazadeh M, Tabrizi N. Cheraghmakani H, et al. Among authors: rahimzadeh g. Epilepsy Res. 2021 Oct;176:106742. doi: 10.1016/j.eplepsyres.2021.106742. Epub 2021 Aug 15. Epilepsy Res. 2021. PMID: 34419770
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials.
Rezai MS, Ahangarkani F, Hill A, Ellis L, Mirchandani M, Davoudi A, Eslami G, Roozbeh F, Babamahmoodi F, Rouhani N, Alikhani A, Najafi N, Ghasemian R, Mehravaran H, Hajialibeig A, Navaeifar MR, Shahbaznejad L, Rahimzadeh G, Saeedi M, Alizadeh-Navai R, Moosazadeh M, Saeedi S, Razavi-Amoli SK, Rezai S, Rostami-Maskopaee F, Hosseinzadeh F, Movahedi FS, Markowitz JS, Valadan R. Rezai MS, et al. Among authors: rahimzadeh g. Front Med (Lausanne). 2022 Jun 16;9:919708. doi: 10.3389/fmed.2022.919708. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35783616 Free PMC article.
Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial study.
Samaee HR, Eslami G, Rahimzadeh G, Saeedi M, Davoudi Badabi A, Asare-Addo K, Nokhodchi A, Roozbeh F, Moosazadeh M, Ghasemian R, Alikhani A, Rezai MS. Samaee HR, et al. Among authors: rahimzadeh g. J Drug Deliv Sci Technol. 2023 Jun;84:104486. doi: 10.1016/j.jddst.2023.104486. Epub 2023 Apr 20. J Drug Deliv Sci Technol. 2023. PMID: 37123173 Free PMC article.
13 results